Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hironori Fukuda
Observed names:
H. Fukuda,
H., Fukuda,
HIRONORI FUKUDA
Institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University,
National Cancer Center Research Institute
Observed institutions:
National Cancer Centre Japan,
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University,
National Cancer Center Research Institute
ORCID:
0009-0008-3009-0146
Observed ORCID:
0009-0008-3009-0146
OpenAlex ID:
A5073431810
Works
246
Awards
3
Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab
2019
·
Hiroki Ishihara
, Toshio Takagi
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
95
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma
2019
·
Hiroki Ishihara
, Hidekazu Tachibana
, et al.
·
Targeted Oncology
·
73
Acquired cystic disease‐associated renal cell carcinoma is the most common subtype in long‐term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi‐institutional study
2018
·
Tsunenori Kondo
, Naoto Sasa
, et al.
·
Pathology International
·
54
PDF
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy
2018
·
Hironori Fukuda
, Toshio Takagi
, et al.
·
Oncotarget
·
47
PDF
A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion
2018
·
Hironori Fukuda
, Ikuma Kato
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
42
Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer
2024
·
Kana Ohashi
, Yukari Nishito
, et al.
·
Scientific Reports
·
39
PDF
Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
2021
·
Takashi Ikeda
, Hiroki Ishihara
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
34
Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma
2020
·
Hidekazu Tachibana
, Tsunenori Kondo
, et al.
·
Japanese Journal of Clinical Oncology
·
32
Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era
2020
·
Hiroki Ishihara
, Toshio Takagi
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
30
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution
2020
·
Toshio Takagi
, Kazuhiko Yoshida
, et al.
·
International Journal of Clinical Oncology
·
30
Predictive impact of an early change in serum C-reactive protein levels in nivolumab therapy for metastatic renal cell carcinoma
2019
·
Hiroki Ishihara
, Toshio Takagi
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
30
Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy
2018
·
Ryo Ishiyama
, Tsunenori Kondo
, et al.
·
Journal of Endourology
·
30
Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end‐stage renal disease
2020
·
Hiroki Ishihara
, Satoshi Yamashita
, et al.
·
Cancer Science
·
29
PDF
Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era
2020
·
Toshio Takagi
, Hironori Fukuda
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
23
The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy
2021
·
YUKI NEMOTO
, TSUNENORI KONDO
, et al.
·
In Vivo
·
22
PDF
The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease–associated Renal Cell Carcinoma
2019
·
Takashi Ikeda
, Hiroki Ishihara
, et al.
·
Clinical Genitourinary Cancer
·
22
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
2022
·
Maki Yoshino
, Hiroki Ishihara
, et al.
·
Japanese Journal of Clinical Oncology
·
21
Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma
2018
·
Hiroki Ishihara
, Toshio Takagi
, et al.
·
Targeted Oncology
·
21
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data
2024
·
Hiroki Ishihara
, Kenji Omae
, et al.
·
International Journal of Clinical Oncology
·
20
Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study
2023
·
Hiroki Ishihara
, Yuki Nemoto
, et al.
·
Targeted Oncology
·
20
Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
2021
·
Yuki Nemoto
, Hiroki Ishihara
, et al.
·
International Urology and Nephrology
·
20
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study
2021
·
Tsunenori Kondo
, Naoto Sassa
, et al.
·
Pathology
·
17
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy
2019
·
Toshio Takagi
, Hironori Fukuda
, et al.
·
Targeted Oncology
·
17
Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
2018
·
Hironori Fukuda
, Toshio Takagi
, et al.
·
International Journal of Clinical Oncology
·
17
Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma
2017
·
Hiroki Ishihara
, Tsunenori Kondo
, et al.
·
Japanese Journal of Clinical Oncology
·
17
PDF
Show more works
View as search
Works count:
246
Citation count:
1,313
H-index:
20
I10-index:
44
Year
Topic
Type